Otsuka Pakistan Limited (OTSU) will suspend its production operations from December 20, 2025, to January 4, 2026, to carry out scheduled annual preventive maintenance.
The company confirmed that manufacturing activities will resume on January 5, 2026.
The Company is engaged in the manufacturing, marketing, and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods, and medical equipment. The company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan.